• DOI:10.1056/NEJM199909023411001
Corpus ID: 45060523

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

@article{Pitt1999TheEO,
  title={The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.},
  author={B. Pitt and F. Zannad and W. Remme and R. Cody and A. Castaigne and A. Perez and J. Palensky and J. Wittes},
  journal={The New England journal of medicine},
  year={1999},
  volume={341 10},
  pages={
          709-17
        }
}

B. Pitt, F. Zannad, +5 authors J. Wittes

Published 1999

Medicine

The New England journal of medicine

BACKGROUND AND METHODS Aldosterone is important in the pathophysiology of heart failure. In a doubleblind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin. A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo. The primary end point was… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed